ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Avinger Inc

Avinger Inc (AVGR)

1.46
-0.04
( -2.67% )
Actualizado: 11:26:14

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
1.46
Postura de Compra
1.46
Postura de Venta
1.47
Volume Operado de la Acción
24,078
1.38 Rango del Día 1.49
1.22 Rango de 52 semanas 14.00
Capitalización de Mercado [m]
Precio Anterior
1.50
Precio de Apertura
1.49
Última hora de negociación
11:32:44
Volumen financiero
US$ 33,956
Precio Promedio Ponderado
1.4103
Volumen promedio (3 m)
42,244
Acciones en circulación
1,702,226
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.14
Beneficio por acción (BPA)
-10.76
turnover
7.65M
Beneficio neto
-18.32M

Acerca de Avinger Inc

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging consol... Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
1970
Avinger Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker AVGR. The last closing price for Avinger was US$1.50. Over the last year, Avinger shares have traded in a share price range of US$ 1.22 to US$ 14.00.

Avinger currently has 1,702,226 shares in issue. The market capitalisation of Avinger is US$2.55 million. Avinger has a price to earnings ratio (PE ratio) of -0.14.

AVGR Últimas noticias

Final Results

RNS Number:0965T TriVest VCT PLC 10 December 2003 TRIVEST VCT PLC Chairman's Statement I am pleased to present to Shareholders the third Annual Report of the Company for the year...

Net Asset Value

RNS Number:2098O TriVest VCT PLC 31 July 2003 TriVest VCT plc (the "Company") Net Asset Value TriVest VCT plc announces that the unaudited net asset value per share (excluding current...

Interim Results

RNS Number:4703L TriVest VCT PLC 23 May 2003 TRIVEST VCT PLC Chairman's Statement I am pleased to present the Company's Interim Report for the six months ended 31 March, 2003...

Net Asset Value

RNS Number:4353K TriVest VCT PLC 28 April 2003 TriVest VCT plc Net Asset Value TriVest VCT plc announces that the unaudited net asset value per share of the Company as at close...

Directorate Change

RNS Number:2488J TriVest VCT PLC 26 March 2003 TriVest VCT plc Board Change At a Board Meeting held on 25 March 2003, Graeme MacLennan announced his intention to retire as a...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.27-15.60693641621.731.741.222572121.41964067CS
4-0.34-18.88888888891.81.821.22799951.46609339CS
12-2.3-61.1702127663.764.151.22422441.71195953CS
26-1.29-46.90909090912.755.451.22457862.86053432CS
52-9.91-87.159190853111.37141.225265359.14410716CS
156-12.79-89.754385964914.25631.225683039.96575578CS
260-30.49-95.430359937431.95631.22283473313.56497952CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
RDHLRedhill Biopharma Ltd
US$ 0.7551
(96.59%)
245.14M
ATPCAgape ATP Corporation
US$ 0.1683
(45.46%)
120.32M
BBLGBone Biologics Corporation
US$ 2.931
(35.69%)
63.36M
DRMADermata Therapeutics Inc
US$ 2.31
(34.30%)
11.25M
TWGTop Wealth Group Holding Ltd
US$ 1.14
(31.03%)
463.01k
LABStandard BioTools Inc
US$ 1.315
(-41.29%)
6.47M
VWEVintage Wine Estates Inc
US$ 0.0307
(-40.85%)
29.2M
ALXOALX Oncology Holdings Inc
US$ 2.975
(-38.02%)
6.1M
MDJHMDJM Ltd
US$ 1.17
(-27.33%)
5.23M
ATECAlphatec Holdings Inc
US$ 7.685
(-23.91%)
8.95M
RDHLRedhill Biopharma Ltd
US$ 0.7559
(96.80%)
245.14M
NVDANVIDIA Corporation
US$ 111.58
(-4.65%)
239.72M
SQQQProShares UltraPro Short QQQ
US$ 9.10
(5.94%)
166.43M
ATPCAgape ATP Corporation
US$ 0.1683
(45.46%)
120.32M
HUGEFSD Pharma Inc
US$ 0.1055
(4.46%)
76.32M

AVGR Discussion

Ver más
glenn1919 glenn1919 21 horas hace
AVGR..................................https://stockcharts.com/h-sc/ui?s=AVGR&p=W&b=5&g=0&id=p86431144783
👍️0
$oldier Hard $oldier Hard 22 horas hace
$AVGR aw, there she went.
👍️0
$oldier Hard $oldier Hard 6 días hace
$AVGR low floater poking it's nose into oversold territory.
👍️0
Monksdream Monksdream 2 meses hace
AVGR under $2
👍️0
Monksdream Monksdream 2 meses hace
AVGR new 52 week low
👍️0
Monksdream Monksdream 2 meses hace
AVGR new 52 week low
👍️0
Monksdream Monksdream 2 meses hace
AVGR new 52 week low
👍️0
Monksdream Monksdream 4 meses hace
AVGR 10Q due 3/20
👍️0
$oldier Hard $oldier Hard 5 meses hace
Hello darlin, yep here off and on. Traveling some, hunting, fishing coaching a soccer team.
👍️0
joanneg joanneg 5 meses hace
Good Morning dear man...you still around? jumped back on and it seems the old team is all but gone.
👍️0
$oldier Hard $oldier Hard 5 meses hace
$AVGR that works.
👍️0
$oldier Hard $oldier Hard 6 meses hace
Yup, I may buy a few.
👍️0
Monksdream Monksdream 6 meses hace
AVGR new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
AVGR new 52 week low
🌈 1 🍆 1 👎️ 1 🤡 1 🩳 1
$oldier Hard $oldier Hard 7 meses hace
$AVGR, 1.37 mil O/S.
👍️0
Monksdream Monksdream 8 meses hace
AVGR new 52 week low
👍️0
Monksdream Monksdream 8 meses hace
AVGR new 52 week low
👍️0
Cadams05 Cadams05 9 meses hace
I need this to sky rocket to the moon. Come on with a huge announcement please
👍️0
Monksdream Monksdream 9 meses hace
AVGR new 52 week low
👍️0
Monksdream Monksdream 9 meses hace
AVGR new 52 week low
👍️0
Monksdream Monksdream 9 meses hace
AVGR new 52 week low
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Snagged more 4s hot 16$ not long ago like 2 weeks
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Reloaded 4s and 5 last few days. 💥
👍️0
Sun Dance Kid Sun Dance Kid 10 meses hace
Loaded 500 shares at $5.80 come on Rip!
👍️0
Sun Dance Kid Sun Dance Kid 10 meses hace
Buy, buy, buy. Buy all you can, OS back to nasdaq standard and funds raised! Squeeze tjme!
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Bet this goes bananas 🍌 soon over reatction
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Boom 💥
👍️0
Monksdream Monksdream 10 meses hace
They deserved what they got
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Lol
👍️0
Monksdream Monksdream 10 meses hace
Here come the short sellers
👍️0
Monksdream Monksdream 10 meses hace
Item 8.01. Other Events

As previously disclosed, on May 20, 2022, Avinger, Inc., (the “Company”), entered into an At the Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (the “Agent”), as sales agent, pursuant to which the Company may offer and sell shares of the Company’s common stock, par value $0.001 per share (the “Shares”), initially up to an aggregate offering price of $7,000,000, from time to time in an at-the-market public offering. On August 3, 2022, the Company determined to suspend sales under the ATM Agreement and terminated the continuous offering of the initial aggregate offering price of $7,000,000. In March 2023, the Company determined to resume sales under the ATM Agreement, up to an aggregate offering price of $1,149,028 and on September 18, 2023, the Company increased the amount available for sale by up to an additional aggregate offering price of $2,133,181.

The Company has determined to increase the amount available for sale under the ATM Agreement, up to an additional aggregate offering price of $1,074,690. The Shares sold under the ATM Agreement will be offered and sold pursuant to the Company’s shelf registration statement on Form S-3 (Registration No. 333-263922), which was initially filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2022 and declared effective on April 7, 2022, and a prospectus supplement and the accompanying prospectus relating to the at-the-market offering filed with the SEC on September 20, 2023.

Because there is no minimum offering amount required pursuant to the ATM Agreement, the total number of Shares to be sold under the ATM agreement, if any, and proceeds to the Company, if any, are not determinable at this time. The Company expects to use any net proceeds for primarily for working capital and general corporate purposes, which may include research and development of the Company’s Lumivascular platform products, preclinical and clinical trials and studies, regulatory submissions, expansion of its sales and marketing organizations and efforts, intellectual property protection and enforcement and capital expenditures. The Company has not yet determined the amount of net proceeds to be used specifically for any particular purpose or the timing of these expenditures. The Company may use a portion of the net proceeds to acquire complementary products, technologies or businesses or to repay principal on its debt; however, it currently has no binding agreements or commitments to complete any such transactions or to make any such principal repayments from the proceeds of this offering, although it does look for such acquisition opportunities. Accordingly, the Company’s management will have significant discretion and flexibility in applying the net proceeds from the sale of these securities
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
6k at 11.9 wow can’t believe I’m getting so lucky
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
One slap of 100k takes this to 20$ that’s about it
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Another 3 k at 12.7 👍 perfect
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Another 3 k at 12.90
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Bought 5 k shares at 13 for the ride to average up
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Ya they shorted. I loaded 25k in the 7s and 10 k more shares after hours I’m guna scoop a few more before I unload on awls crew
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Squeeze started but won’t dry up till we get another couple 💯 pct
👍️0
Monksdream Monksdream 10 meses hace
Some are kicking themselves for selling during the regular session and not getting back in as the price started rising again in the afternoon
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Enjoy the squeeze 🍋
👍️0
Sun Dance Kid Sun Dance Kid 10 meses hace
Yes!
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
And a few beers 🍻. Take care buddy done ✅ wish you the best
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
I would not count down !count down! I would average up
👍️0
Monksdream Monksdream 10 meses hace
This is all about emotion combined with momentum
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Like 600 min to pre market? Hahah
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
At least it’s no p and d for a few days
👍️0
Monksdream Monksdream 10 meses hace
110 minutes remain
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Wait till 20 at least to sell
For sure md
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Agree but dis agree. Love dreaming monk
Cannons getting 🔥
👍️0
OmegaMoney29 OmegaMoney29 10 meses hace
Sure more news drops 💦
👍️0

Su Consulta Reciente

Delayed Upgrade Clock